WuXi Biologics: Revenue and profit surged on strong demand for high-margin modalities, with guidance raised
WuXi Biologics: Revenue and profit surged on strong demand for high-margin modalities, with guidance raised
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.